By Michael Dabaie Baxter International Inc. and Moderna Inc. said they are in an agreement for Baxter BioPharma Solutions to provide fill/finish sterile manufacturing services and supply packaging for about 60 million to 90 million doses of the Moderna Covid-19 Vaccine in 2021. Baxter s BioPharma Solutions business is a contract manufacturing organization that specializes in injectable pharmaceuticals, including vaccines. The manufacturing of the Moderna Covid-19 vaccine would take place at the BioPharma Solutions fill/finish sterile manufacturing facilities in Bloomington, Ind. The companies didn t disclose additional details of the agreement. Write to Michael Dabaie at michael.dabaie@wsj.com (END) Dow Jones Newswires